Posted on May 20, 2009 by Patients and Patents
Live Twitter updates from the 62nd World Health Assembly: www.twitter.com/patientspatents
Discussions on issues of public health and innovation have been further delayed. They were to be discussed yesterday, but have been rescheduled for later today. With other issues such as climate change, social determinants of health and pandemic influenza preparedness also on the agenda, it seems likely [...]
Filed under: World Health Organization | Tagged: IGWG, Innovation, World Health Assembly, World Health Organization | Leave a Comment »
Posted on May 19, 2009 by Patients and Patents
Live Twitter updates from the 62nd World Health Assembly: www.twitter.com/patientspatents
The 62nd World Health Assembly opened yesterday (May 18, 2009) and much of the administrative details (election of the President, chairmans of the committees, adoption of the agenda, etc.). Dr. Margaret Chan also addressed the Assembly.
The WHA was significantly shortened due to the H1N1 outbreak. As a [...]
Filed under: Public health, World Health Organization | Tagged: H1N1, World Health Assembly, World Health Organization | Leave a Comment »
Posted on December 15, 2008 by kmlybecker
Dr. Kristina M. Lybecker
The safety and efficacy of medicines is something that most patients in developed countries take for granted. Whether it’s a vaccination, prescription, or over the counter drug, most people assume that the medicines they’re getting are legitimate. While bogus drugs are most frequently found in the most vulnerable markets – those of [...]
Filed under: Counterfeit drugs, Public health | Tagged: access to medicines, Counterfeit drugs, counterfeit medicines, patient safety, World Health Assembly | Leave a Comment »
Posted on May 22, 2008 by kmlybecker
On May 20th a draft resolution on counterfeit medical products was submitted to the World Health Assembly by the nations of Gambia, Ghana, Nigeria, Tunisia and the United Arab Emirates. As the WHA turns to the challenges surrounding counterfeit pharmaceuticals, it is valuable to reflect on the threat counterfeit drugs pose. In particular, it is [...]
Filed under: Counterfeit drugs | Tagged: counterfeit medicines, patients, World Health Assembly | Leave a Comment »
Posted on May 20, 2008 by Patients and Patents
The WHO’s Intergovernmental Working Group on Public Health, Innovation and Intellectual Property will present their incomplete draft strategy at this week’s 61st World Health Assembly.
Unfortunately, unless you’re a lawyer or government policy analyst, it is difficult to understand what the real reccomendations are. For everyone else, here is an easy to understand overview of the [...]
Filed under: IGWG | Tagged: IGWG, World Health Assembly, World Health Organization | Leave a Comment »
Posted on May 13, 2008 by Patients and Patents
The World Health Organization’s Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG) met for the continuation of its second session in Geneva at the end of April. While they didn’t achieve consensus on all elements of their draft plan, there were many areas of agreement.
Some of the points of consensus include:
Intellectual property [...]
Filed under: IGWG | Tagged: IGWG, Innovation, World Health Assembly | Leave a Comment »
World Health Assembly to be cut short due to swine flu
Earlier this week, the UN announced that the sixty-second World Health Assembly would be cut short due to global concerns about the spread of influenza A (H1N1) – swine flu. Instead of the previously scheduled 10 day meeting (May 18-27), the WHA will be cut in half and will run from May 18-22, 2009.
Due to the [...]
Filed under: Commentary on news & events | Tagged: H1N1, Swine flu, World Health Assembly, World Health Organization | 2 Comments »